1887

Journal of Medical Microbiology logo

Volume 65, Issue 11

Disparate prevalence of toxigenic and nontoxigenic among distinct adult patient populations in a single institution Free

Abstract

(CD) disease remains a costly and important hospital-associated infection. Although nontoxigenic CD is detected by some CD testing methods, can interfere with some detection algorithms and has been suggested as a treatment for CD disease, little is known about the relative occurrence of toxigenic and nontoxigenic CD in a single institution.We used both chromogenic and selective agar media to recover CD isolates and a molecular method to detect the toxin B gene from over 2400 fresh unformed stool specimens with isolates further tested for the toxin B gene. We recovered 74 nontoxigenic and 306 toxigenic CD isolates for which a collection site could be assigned.The frequency of recovery of toxigenic and nontoxigenic CD for each hospital location and the ratio of toxigenic to nontoxigenic CD were calculated. Although the overall prevalence of toxigenic and nontoxigenic CD was 12.7 % and 3.1 %, respectively, on some wards, 48 % of all CD were nontoxigenic, while on other wards, ≤5 % were nontoxigenic.The disparate ratios of nontoxigenic CD to toxigenic CD presented here for the various ‘groups’ within the adult veteran population are important to the ongoing discussion and reexamination of other published work on the occurrence of toxigenic and nontoxigenic CD, for evaluating the performance of CD detection tests, for designing infection control strategies and in ultimately understanding both CD carriage and disease.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Cepheid , chromogenic agar , Clostridium difficile , nontoxigenic and toxigenic
© 2016 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000350
2016-11-16
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/11/1237.html?itemId=/content/journal/jmm/10.1099/jmm.0.000350&mimeType=html&fmt=ahah

References

  1. Babady N. E., Stiles J., Ruggiero P., Khosa P., Huang D., Shuptar S., Kamboj M., Kiehn T. E. 2010; Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 48:4519–4524 [View Article][PubMed]
     [Google Scholar]
  2. Bamber A., Fitzsimmons K., Cunniffe J. G., Beasor C. C., Mackintosh C. A., Hobbs G. 2012; Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification. Br J Biomed Sci 69:112–118[PubMed]
     [Google Scholar]
  3. Barbut F., Delmée M., Brazier J. S., Petit J. C., Poxton I. R., Rupnik M., Lalande V., Schneider C., Mastrantonio P. et al. 2003; A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9:989–996 [View Article][PubMed]
     [Google Scholar]
  4. Boone J. H., Goodykoontz M., Rhodes S. J., Price K., Smith J., Gearhart K. N., Carman R. J., Kerkering T. M., Wilkins T. D. et al. 2012; Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency. Eur J Clin Microbiol Infect Dis 31:1551–1559 [View Article][PubMed]
     [Google Scholar]
  5. Carson K. C., Boseiwaqa L., Thean S. K., Foster N. F., Riley T. 2013; Isolation of Clostridium difficile from faecal specimens – a comparison of ChromID C. difficile agar and cycloserine-cefoxitin-fructose agar. J Med Microbiol 62:1423–1427 [View Article][PubMed]
     [Google Scholar]
  6. Culbreath K., Ager E., Nemeyer R. J., Kerr A., Gilligan P. H. 2012; Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J Clin Microbiol 50:3073–3076 [View Article][PubMed]
     [Google Scholar]
  7. Dalpke A. H., Hofko M., Zorn M., Zimmermann S. 2013; Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens. J Clin Microbiol 51:1906–1908 [View Article][PubMed]
     [Google Scholar]
  8. Delmée M. 2001; Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7:411–416 [View Article][PubMed]
     [Google Scholar]
  9. Delmée M., Verellen G., Avesani V., Francois G. 1988; Clostridium difficile in neonates: serogrouping and epidemiology. Eur J Pediatr 147:36–40 [View Article][PubMed]
     [Google Scholar]
  10. Dubberke E. R., Han Z., Bobo L., Hink T., Lawrence B., Copper S., Hoppe-Bauer J., Burnham C. A., Dunne W. M. 2011; Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 49:2887–2893 [View Article][PubMed]
     [Google Scholar]
  11. Eckert C., Burghoffer B., Lalande V., Barbut F. 2013; Evaluation of the chromogenic agar ChromID C. difficile. J Clin Microbiol 51:1002–1004 [View Article][PubMed]
     [Google Scholar]
  12. Fenner L., Widmer A. F., Goy G., Rudin S., Frei R. 2008; Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46:328–330 [View Article][PubMed]
     [Google Scholar]
  13. Furuya-Kanamori L., Marquess J., Yakob L., Riley T. V., Paterson D. L., Foster N. F., Huber C. A., Clements A. C. 2015; Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis 15:516 [View Article][PubMed]
     [Google Scholar]
  14. Goldenberg S. D., Dieringer T., French G. L. 2010; Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction. Diagn Microbiol Infect Dis 67:304–307 [View Article][PubMed]
     [Google Scholar]
  15. Hernández-Rocha C., Barra-Carrasco J., Álvarez-Lobos M., Paredes-Sabja D., Guzmán-Durán A. M. 2013; Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections. Diagn Microbiol Infect Dis 75:361–365 [View Article][PubMed]
     [Google Scholar]
  16. Mahlen S. D., Clarridge J. E. 2011; Evaluation of a selection strategy before use of 16S rRNA gene sequencing for the identification of clinically significant Gram-negative rods and coccobacilli. Am J Clin Pathol 136:381–388 [View Article][PubMed]
     [Google Scholar]
  17. McFarland L. 2011; Emerging therapies for Clostridium difficile infections. Expert Opin Emerg Drugs 16:425–439 [View Article][PubMed]
     [Google Scholar]
  18. Nagaro K. J., Phillips S. T., Cheknis A. K., Sambol S. P., Zukowski W. E., Johnson S., Gerding D. N. 2013; Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother 57:5266–5270 [View Article][PubMed]
     [Google Scholar]
  19. Peterson L. R., Mehta M. S., Patel P. A., Hacek D. M., Harazin M., Nagwekar P. P., Thomson R. B., Robicsek A. 2011; Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am J Clin Pathol 136:372–380 [View Article][PubMed]
     [Google Scholar]
  20. Poilane I., Humeniuk-Ainouz C., Durand I., Janoir C., Cruaud P., Delmée M., Popoff M. R., Collignon A. 2007; Molecular characterization of Clostridium difficile clinical isolates in a geriatric hospital. J Med Microbiol 56:386–390 [View Article][PubMed]
     [Google Scholar]
  21. Rousseau C., Lemée L., Le Monnier A., Poilane I., Pons J. L., Collignon A. 2011; Prevalence and diversity of Clostridium difficile strains in infants. J Med Microbiol 60:1112–1118 [View Article][PubMed]
     [Google Scholar]
  22. Rousseau C., Poilane I., De Pontual L., Maherault A. C., Le Monnier A., Collignon. 2012; Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin Infect Dis 55:1209–1215 [View Article][PubMed]
     [Google Scholar]
  23. Sambol S. P., Merrigan M. M., Tang J. K., Johnson S., Gerding D. N. 2002; Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 186:1781–1789 [View Article][PubMed]
     [Google Scholar]
  24. Shim J. K., Johnson S., Samore M. H., Bliss D. Z., Gerding D. N. 1998; Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633–636 [View Article][PubMed]
     [Google Scholar]
  25. Shin S., Kim M., Kim M., Lim H., Kim H., Lee K., Chong Y. 2012; Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med 32:355–358 [View Article][PubMed]
     [Google Scholar]
  26. Surawicz C. M., Brandt L. J., Binion D. G., Ananthakrishnan A. N., Curry S. R., Gilligan P. H., McFarland L. V., Mellow M., Zuckerbraun B. S. 2013; Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108:478–498 [View Article][PubMed]
     [Google Scholar]
  27. Tenover F. C., Novak-Weekley S., Woods C. W., Peterson L. R., Davis T., Schreckenberger P., Fang F. C., Dascal A., Gerding D. N. et al. 2010; Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 48:3719–3724 [View Article][PubMed]
     [Google Scholar]
  28. Tenover F. C., Baron E. J., Peterson L. R., Persing D. H. 2011; Laboratory diagnosis of Clostridium difficile infection: can molecular amplification methods move us out of uncertainty?. J Mol Diagn 13:573–582 [View Article][PubMed]
     [Google Scholar]
  29. Viala C., Le Monnier A., Maataoui N., Rousseau C., Collignon A., Poilane I. 2012; Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile. J Microbiol Methods 90:83–85 [View Article][PubMed]
     [Google Scholar]
  30. Williamson D. A., Basu I., Freeman J., Swager T., Roberts S. A. 2013; Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword. Am J Infect Control 41:270–272 [View Article][PubMed]
     [Google Scholar]
  31. Wren M. W. D., Kinson R., Sivapalan M., Shemko M., Shetty N. P. 2009a; Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm. Br J Biomed Sci 66:175–179 [View Article]
     [Google Scholar]
  32. Wren M. W. D., Sivapalan M., Kinson R., Shetty N. P. 2009b; Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory. Br J Biomed Sci 66:1–5 [View Article]
     [Google Scholar]
  33. Zilberberg M. D., Tillotson G. S., McDonald L. C. 2010; Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerg Infect Dis 16:604–609 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000350
Loading
Disparate prevalence of toxigenic and nontoxigenic Clostridium difficile among distinct adult patient populations in a single institution
J. Med. Microbiol. 65, 1237 (2016); https://doi.org/10.1099/jmm.0.000350
/content/journal/jmm/10.1099/jmm.0.000350
/content/journal/jmm/10.1099/jmm.0.000350
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error